Transthyretin (TTR) is involved in a subset of familial or sporadic amyloid diseases including senile systemic amyloidosis (SSA), familial amyloid polyneuropathy and cardiomyopathy (FAP/FAC) for which no effective therapy has been found yet. These conditions are characterized by extracellular deposits primarily found in the heart parenchyma and in peripheral nerves whose main component are amyloid fibrils, presently considered the main culprits of cell sufferance. The latter are polymeric assemblies grown from misfolded TTR, either wt or carrying one out of many identified mutations. The recent introduction in the clinical practice of synthetic TTR-stabilizing molecules that reduce protein aggregation provides the rationale to search natural effective molecules able to interfere with TTR amyloid aggregation by hindering the appearance of toxic species or by favoring the growth of harmless aggregates. Here we carried out an in depth biophysical and morphological study on the molecular features of the aggregation of wt- and L55P-TTR involved in SSA or FAP/FAC, respectively, and on the interference with fibril aggregation, stability and toxicity to cardiac HL-1 cells to demonstrate the ability of Oleuropein aglycone (OleA), the main phenolic component of the extra virgin olive oil. We describe the molecular basis of such interference and the resulting reduction of TTR amyloid aggregate cytotoxicity. Our data offer the possibility to validate and optimize the use of OleA or its molecular scaffold to rationally design promising drugs against TTR-related pathologies that could enter a clinical experimental phase.

Leri, M., Nosi, D., Natalello, A., Porcari, R., Ramazzotti, M., Chiti, F., et al. (2016). The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 30, 153-166 [10.1016/j.jnutbio.2015.12.009].

The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies

NATALELLO, ANTONINO;DOGLIA, SILVIA MARIA;
2016

Abstract

Transthyretin (TTR) is involved in a subset of familial or sporadic amyloid diseases including senile systemic amyloidosis (SSA), familial amyloid polyneuropathy and cardiomyopathy (FAP/FAC) for which no effective therapy has been found yet. These conditions are characterized by extracellular deposits primarily found in the heart parenchyma and in peripheral nerves whose main component are amyloid fibrils, presently considered the main culprits of cell sufferance. The latter are polymeric assemblies grown from misfolded TTR, either wt or carrying one out of many identified mutations. The recent introduction in the clinical practice of synthetic TTR-stabilizing molecules that reduce protein aggregation provides the rationale to search natural effective molecules able to interfere with TTR amyloid aggregation by hindering the appearance of toxic species or by favoring the growth of harmless aggregates. Here we carried out an in depth biophysical and morphological study on the molecular features of the aggregation of wt- and L55P-TTR involved in SSA or FAP/FAC, respectively, and on the interference with fibril aggregation, stability and toxicity to cardiac HL-1 cells to demonstrate the ability of Oleuropein aglycone (OleA), the main phenolic component of the extra virgin olive oil. We describe the molecular basis of such interference and the resulting reduction of TTR amyloid aggregate cytotoxicity. Our data offer the possibility to validate and optimize the use of OleA or its molecular scaffold to rationally design promising drugs against TTR-related pathologies that could enter a clinical experimental phase.
Articolo in rivista - Articolo scientifico
Amyloid; FAC; FAP; Oleuropein aglycone; Transthyretin;
Amyloid; FAC; FAP; Oleuropein aglycone; Transthyretin; Endocrinology, Diabetes and Metabolism; Biochemistry; Molecular Biology; Nutrition and Dietetics; Clinical Biochemistry
English
2016
30
153
166
partially_open
Leri, M., Nosi, D., Natalello, A., Porcari, R., Ramazzotti, M., Chiti, F., et al. (2016). The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 30, 153-166 [10.1016/j.jnutbio.2015.12.009].
File in questo prodotto:
File Dimensione Formato  
Leri-2016-J Nutrit Biochem-VoR.pdf

Solo gestori archivio

Descrizione: Research Article
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 2.96 MB
Formato Adobe PDF
2.96 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Leri-2016-J Nutrit Biochem-AAM.pdf

accesso aperto

Descrizione: Research Article
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Creative Commons
Dimensione 783.23 kB
Formato Adobe PDF
783.23 kB Adobe PDF Visualizza/Apri
Leri-2016-J Nutrit Biochem-AAM.pdf

accesso aperto

Descrizione: figura supplementare
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Creative Commons
Dimensione 399.12 kB
Formato Adobe PDF
399.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/138009
Citazioni
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 36
Social impact